People Matter
Eligo Bioscience
Eligo Bioscience
eligo.bio

Locations

Île-de-France, France · Paris, France

industry

Biotechnology · DeepTech · Health

Size

11-50 employees

Stage

Other

founded in

2014

Eligobiotics is a developer of antibiotics intended to treat microbiome precision and bacteria-associated diseases. The company's antibiotics combine CRISPR/Cas system with engineered phage capsids, to develop antimicrobials that are used to eradicate resistant pathogens or virulent bacteria within the human microbiome, enabling clients to get next-generation antimicrobials to treat diseases caused by superbugs.

Something looks off?
Open jobs at Eligo Bioscience
Powered by Getro